STING1 and autoimmune disease: A increasing amount of researches have shown that the immoderate activation of cGAS-STING pathway could trigger a range of inflammatory responses and autoimmune diseases, including alcoholic liver disease (Chen R. et al., 2021), ischemic brain injury (Li et al., 2023) and rheumatoid arthritis (Wang J. et al., 2019).